{"title":"Undetectable MRD on maintenance venetoclax, acalabrutinib, and obinutuzumab in the majority of R/R CLL participants","authors":"Robert van den Heuvel","doi":"10.55788/11dff369","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"23 20","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report ASH 2023","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/11dff369","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
